Over the years, COPD has grown to meet the expanding needs of our clients, continually offering new programs and services.
Ensure the smoking status of each patient is recorded and up-to-date. Flag current smokers for brief smoking cessation advice or referral to local programs.
Support smoking cessation The single most important intervention to prevent or slow the progression of COPD is smoking cessation; it preserves residual lung function at any stage of the disease and delays the onset of disability and death. There is evidence to show that personalising smoking cessation advice based on Copd case age and the lung age calculator may increase cessation rates.
The Lung Age Estimator is a visually effective tool developed to support clinicians motivate current smokers to quit by providing a graphic illustration of estimated lung age. The Royal Australian College of General Practitioners has developed an excellent resource to support smoking cessation in general practice: Best practice is summarised in the Copd case strategy: Ask and identify smokers at every visit Advise about the risks of smoking and benefits of quitting Assess the motivation to quit Assist cessation Arrange follow-up within a week of the quit date and one month after For smokers who continue to smoke, offer both counselling and nicotine dependence treatment provided there are no contraindications.
Higher dose forms of NRT 4mg are more effective than lower dose forms 2mg for more addicted smokers and can be used while patients are still smoking. More than one form of NRT can be used concurrently with increased success rates and no safety risks. Varenicline - Varenicline was developed to counteract the effects of nicotine on the nAChR brain receptors.
A week course of treatment is recommended. In the first 4 weeks smokers should start varenicline and then set a quit date weeks after starting, but a later date is sometimes appropriate. The dose is as follows: To reduce relapse, patients who successfully quit at 12 weeks can be prescribed another 12 weeks of varenicline.
Bupropion - Bupropion increases quit rates compared to placebo and is effective for smokers with depression, cardiac disease and respiratory disease, including COPD. The recommended dose is mg orally once daily for three days, then mg twice daily.
Bupropion is available as a starter pack of 30 tablets and a continuation pack of 90 tablets. The patient should stop smoking in the second week of treatment. The following interventions have been shown to be effective in supporting people to stop smoking, including: Evidence obtained from systematic review of relevant randomised controlled trials Smoking cessation advice from health professionals is effective in increasing quit rates.
The major effect is to help motivate a quit attempt. All health professionals can be effective in providing smoking cessation advice. Brief smoking cessation advice from health professionals delivered opportunistically during routine consultations has a modest effect size, but substantial potential public health benefit.Tiotropium delivered at a dose of 5 μg with the Respimat inhaler showed efficacy similar to that of 18 μg of tiotropium delivered with the HandiHaler inhalation device in placebo-controlled.
COPD Canada is a non-profit association and patient advocacy group focused on providing educational materials, services and support for people living with Chronic Obstructive Pulmonary Disease (COPD).
CHEST Annual Meeting Abstracts. Find abstracts of original investigations from slides and posters presented at CHEST , held October , in San Antonio, Texas, featuring essential updates in lung diseases, improving patient care, and trends in morbidity and mortality..
Browse the CHEST Annual Meeting abstracts. Your Virtual or Real Age, shown by this Free Real Age Life Expectancy Calculator can be used to determine your health, care for your body, vitality, life expectancy and for insurance purposes..
Consider this a tool to calculate your actual or real / true age test based on gender, weight, build, biological age, stress, sleep, cholesterol, blood pressure, smoking, CAD history, heart problems.
Chronic obstructive pulmonary disease (COPD) is a collection of lung diseases that cause blocked airways and make breathing difficult. It can result in serious complications. What is COPD? Chronic obstructive pulmonary disease, or COPD, refers to a group of diseases that cause airflow blockage and breathing-related problems.